Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
Tóm tắt
Cigarette smoking is a major risk factor for atherosclerosis and other cardiovascular diseases. Increasing evidence has demonstrated that nicotine impairs the cardiovascular system by targeting vascular endothelial cells, but the underlying mechanisms remain obscure. It is known that cell death and inflammation are crucial processes leading to atherosclerosis. We proposed that pyroptosis may be implicated in nicotine-induced atherosclerosis and therefore conducted the present study. We found that nicotine resulted in larger atherosclerotic plaques and secretion of inflammatory cytokines in ApoE−/− mice fed with a high-fat diet (HFD). Treatment of human aortic endothelial cells (HAECs) with nicotine resulted in NLRP3-ASC inflammasome activation and pyroptosis, as evidenced by cleavage of caspase-1, production of downstream interleukin (IL)-1β and IL-18, and elevation of LDH activity and increase of propidium iodide (PI) positive cells, which were all inhibited by caspase-1 inhibitor. Moreover, silencing NLRP3 or ASC by small interfering RNA efficiently suppressed nicotine-induced caspase-1 cleavage, IL-18 and IL-1β production, and pyroptosis in HAECs. Further experiments revealed that the nicotine-NLRP3-ASC-pyroptosis pathway was activated by reactive oxygen species (ROS), since ROS scavenger (N-acetyl-cysteine, NAC) prevented endothelial cell pyroptosis. We conclude that pyroptosis is likely a cellular mechanism for the pro-atherosclerotic property of nicotine and stimulation of ROS to activate NLRP3 inflammasome is a signaling mechanism for nicotine-induced pyroptosis.
Từ khóa
Tài liệu tham khảo
Wilhelmsen, L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am. Heart J. 115, 242–249 (1988).
Hecht, S. S. & Hoffmann, D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8, 273–294 (1989).
Ockene, I. S. & Miller, N. H. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 96, 3243–3247 (1997).
Lee, J. & Cooke, J. P. The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis 215, 281–283 (2011).
Heeschen, C. et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 7, 833–839 (2001).
Welsh, P., Grassia, G., Botha, S., Sattar, N. & Maffia, P. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? Br. J. Pharmacol. 174, 3898–3913 (2017).
Miao, E. A. et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11, 1136–1142 (2010).
Miao, E. A., Rajan, J. V. & Aderem, A. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243, 206–214 (2011).
Lin, J. et al. Oxidized low density lipoprotein induced caspase-1 mediated pyroptotic cell death in macrophages: implication in lesion instability? PLoS. One. 8, e62148 (2013).
Roumenina, L. T., Rayes, J., Frimat, M. & Fremeaux-Bacchi, V. Endothelial cells: source, barrier, and target of defensive mediators. Immunol. Rev. 274, 307–329 (2016).
Nawa, T. et al. Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161, 281–291 (2002).
Mollace, V. et al. Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: role of oxidative stress and LOX-1 receptor expression. Int. J. Cardiol. 184, 152–158 (2015).
Yin, Y. et al. Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arterioscler. Thromb. Vasc. Biol. 35, 804–816 (2015).
Gage, J., Hasu, M., Thabet, M. & Whitman, S. C. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can. J. Cardiol. 28, 222–229 (2012).
Lau, P. P. et al. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(−/−) mice. Arterioscler. Thromb. Vasc. Biol. 26, 143–149 (2006).
Kilaru, S. et al. Nicotine: a review of its role in atherosclerosis. J. Am. Coll. Surg. 193, 538–546 (2001).
Wang, C. et al. Nicotine accelerates atherosclerosis in apolipoprotein e-deficient mice by activating alpha7 nicotinic acetylcholine receptor on mast cells. Arterioscler. Thromb. Vasc. Biol. 37, 53–65 (2017).
Takahashi, M. NLRP3 inflammasome as a novel player in myocardial infarction. Int. Heart J. 55, 101–105 (2014).
Ambrose, J. A. & Barua, R. S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43, 1731–1737 (2004).
Al Rifai, M. et al. The relationship between smoking intensity and subclinical cardiovascular injury: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 258, 119–130 (2017).
Ezzati, M., Henley, S. J., Thun, M. J. & Lopez, A. D. Role of smoking in global and regional cardiovascular mortality. Circulation 112, 489–497 (2005).
Santanam, N. et al. Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis 225, 264–273 (2012).
Reglero-Real, N., Colom, B., Bodkin, J. V. & Nourshargh, S. Endothelial cell junctional adhesion molecules: role and regulation of expression in inflammation. Arterioscler. Thromb. Vasc. Biol. 36, 2048–2057 (2016).
Manes, T. D. & Pober, J. S. Significant differences in antigen-induced transendothelial migration of human CD8 and CD4 T effector memory cells. Arterioscler. Thromb. Vasc. Biol. 36, 1910–1918 (2016).
Davies, P. F. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat. Clin. Pract. Cardiovasc. Med. 6, 16–26 (2009).
Wang, C. N. et al. Role of perivascular adipose tissue in nicotine-induced endothelial cell inflammatory responses. Mol. Med. Rep. 14, 5713–5718 (2016).
Wang, Y., Zhang, F., Yang, W. & Xue, S. Nicotine induces pro-inflammatory response in aortic vascular smooth muscle cells through a NFkappaB/osteopontin amplification loop-dependent pathway. Inflammation 35, 342–349 (2012).
Chang, W., Lin, J., Dong, J. & Li, D. Pyroptosis: an inflammatory cell death implicates in atherosclerosis. Med. Hypotheses 81, 484–486 (2013).
Li, X. et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 5, e1479 (2014).
Franchi, L., Eigenbrod, T., Munoz-Planillo, R. & Nunez, G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10, 241–247 (2009).
Sagulenko, V. et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. 20, 1149–1160 (2013).
Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898–910 (2014).
Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).
Karasawa, T. & Takahashi, M. Role of NLRP3 inflammasomes in atherosclerosis. J. Atheroscler. Thromb. 24, 443–451 (2017).
Latz, E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 22, 28–33 (2010).
Zhang, Y. et al. MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Sci. Rep. 5, 9401 (2015).
Sun, X. et al. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J. Clin. Invest. 122, 1973–1990 (2012).